ISPC — iSpecimen Inc.
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1558569 ·
Last close
$1.89
Market Cap
$2.72M
52W High
$6.77
52W Low
$1.77
ADV30
90,870
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 156,009 | 71,599 | -2,538,403 | -2,275,221 | 6,609,658 | 2,818,989 | 5,795,620 |
| Dec 2025 | 51,761 | -547,078 | -2,687,882 | -5,001,245 | 9,531,410 | 6,880,835 | 6,443,179 |
| Sep 2025 | 106,592 | -98,001 | -2,830,222 | -2,780,648 | 8,997,557 | 2,782,758 | 5,924,846 |
| Jun 2025 | 713,135 | 268,958 | -1,821,426 | -1,047,243 | 6,034,501 | 588,775 | 5,412,528 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-6,506,609
Investing CF
$-1,700,454
Financing CF
$10,243,489
CapEx
$-1,953,011
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-330.95
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-84,625,370
Inventory
$0
Receivables
$132,848
ST Investments
$0
EBIT TTM
$-11,101,983
Pretax Income TTM
$-11,104,357
Interest Exp TTM
$2,374
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,027,497
EBITDA
$-9,680,486
Free Cash Flow
$-5,687,161
Enterprise Value
$152,226
Total Cash
$2,818,989
Total Debt
$254,989
Shares Out
1,437,157
Trailing EPS
$-329.05
Book Value
$1.10
ROE
-894.6%
ROA
-91.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,928,998 | -8,977,919 | -10,487,532 | 9,531,410 | 6,443,179 | — | -4,240,608 |
| Dec 2024 | 9,291,115 | -12,728,045 | -12,497,805 | 9,350,230 | 6,039,222 | — | -8,263,713 |
| Dec 2023 | 9,928,184 | -11,169,349 | -11,099,488 | 15,819,137 | 6,078,060 | — | -5,807,550 |
| Dec 2022 | 10,402,303 | -10,186,082 | -10,245,922 | 24,617,653 | 4,308,483 | — | -5,817,720 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.79
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BUDZ | WEED, INC. | $2.97M | $0.02 | — |
| VRAX | Virax Biolabs Group Ltd | $2.09M | $2.62 | — |
| NYMXF | NYMOX PHARMACEUTICAL CORP | $1.89M | $0.02 | — |
| BIAF | bioAffinity Technologies, Inc. | $3.94M | $0.63 | — |
| CBIH | Cannabis Bioscience International Holdings, Inc. | $1.74M | $0.00 | — |
News headlines (Yahoo Finance, 1h cache)
E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement
2026-05-12 18:16 · Yahoo
iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement
2026-05-09 01:04 · Yahoo
iSpecimen Announces 1-for-40 Reverse Stock Split
2026-04-24 13:00 · Yahoo
iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time
2026-04-09 20:05 · Yahoo
iSpecimen Achieves Rapid Procurement Milestone for Influenza Research
2026-03-16 11:47 · Yahoo
BC-Most Active Stocks
2026-03-13 14:30 · Yahoo
Wall Street Set to Open Higher Friday as Investors Parse Inflation Data, Oil Prices
2026-03-13 13:23 · Yahoo
iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching
2026-03-12 20:05 · Yahoo
iSpecimen Announces Milestone 2: System Integration and Marketplace Activation Complete
2026-02-06 14:30 · Yahoo
Nuwellis Announces Changes to Board of Directors
2026-01-23 21:40 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.